Our approach is aligned with our mission and values and focuses on four key priorities: access to medicines, environmental sustainability, employee health and well-being, and ethics and transparency Ina Bulat
Our core values are driven by a desire to improve life, achieve scientific excellence, operate with the highest standards of integrity, expand access to our products and employ a diverse workforce that values collaboration.
Merck Serbia is engaged in innovative medicines. Which medicines are you focused on in Serbia?
– Innovation is what creates success for Merck, which is why the company invests more than a billion euros a year in development. With comprehensive experience worldwide, Merck has the option to transfer its experience to the Serbian health system. We are very pleased that we were able to introduce a gold standard in the treatment of many diseases in Serbia, in line with world practices, for example in neurodegenerative diseases like multiple sclerosis, malignant diseases and endocrinology.
One of the areas the company is dedicated to is multiple sclerosis. Skills, time and resources are required for the development of new, revolutionary medicines. We want to improve the efficiency of the treatment of patients in the world and in our country by researching this therapeutic area.
Merck is also a leader in the field of endocrine disorders, and in addition to contemporary treatment for thyroid gland disorders, the Company has medicine that treats growth hormone deficiency.
We focus on what’s important, and that is to provide the right medicine to patients in need. I am proud of the fact that every year we have to offer something new to our market, a fact that is not a simple process
There is much talk these days about the lack of innovative drugs for some of the most serious diseases in Serbia. How can your company help with that?
– I am proud of the fact that Merck produces medicines that ease patients’ daily lives and with their proper use we can prevent the progression of the disease. To us, the patients and their well-being come first, and we are doing everything we can to improve the quality of life of our patients so that they can, with timely treatment in most cases, live and work normally, avoid costly and complicated procedures, and enjoy daily activities.
Innovative solutions can often achieve and improve medical care for patients and still bring savings in the budget of the country, but it is necessary to consider the total cost of treatment and not only expenditure on drugs. Merck, as a socially responsible company, will seek, as before, to improve the health system of Serbia, through donations for the benefit of patients in the form of medicines, equipment, training of health care providers, etc.
What are the standards and procedures that Merck Serbia follows and are they different from other 140 Merck offices in the world?
– Merck is the oldest pharmaceutical and chemical company in the world, having existed for 350 years. It has been present in Serbia since 2006. The main goal of the company is to make quality and innovative medicines available to a larger number of patients. The highest standards and patients are at the forefront of all our offices, and these values characterise Merck as a company.